Mechanistically, the presence of cytosolic, tumor-derived DNA in immune cells is recognized by cyclic GMP-AMP synthase (cGAS) which activates stimulator of interferon (IFN) genes (STING), leading to IFN-beta production and CD8+ T cell priming [178]. Here, STING1 is linked to neoplasm.